Rocket Fuel
Advanced Search
Print    Email
Decrease (-) Restore Default Increase (+)
Find a Physician

Gynecologic Cancer Clinical Trials

Please check with your doctor or call 1-855-HCH-HOPE (424-4673) to find out if you qualify for any of these studies.

Trial  #

Trial Sub-type            

Title

GOG – 0263
NCI

Cervical Cancer, Stage I-IIA, Previously Underwent Surgery

 

Randomized Phase III Clinical Trial of Adjuvant Radiation Versus Chemoradiation in Intermediate Risk, Stage I/IIA Cervical Cancer Treated with Initial Radical Hysterectomy and Pelvic Lymphadenectomy.

RTOG 1203

Pathologically proven diagnosis of endometrial or cervical cancer within 90 days of registration

 A randomized phase III study of standard vs. IMRT pelvic radiation for post-operative treatment of endometrial and cervical cancer (TIME-C).

RTOG 0724
NCI

Patients with cervical cancer after hysterectomy.

Phase III randomized study of concurrent chemotherapy and pelvic radiation therapy with or without adjuvant chemotherapy in high-risk patients with ealry-stage cervical carcinoma following radical hysterectomy.

Yale University School of Medicine

Surgically Staged III-IV (TAH/BSO/Washings/PPAL D) or Recurrent Uterine Serous Papillary Carcinoma Patients with Measurable Disease

A Randomized Phase III Evaluation of Carboplatin/paclitaxel with and without Trastuzumab (Herceptin®) in HER2/neu+ Patients with advanced/Recurrent Uterine Serous Papillary Carcinoma

 

 

 

  Holy Cross Hospital
  Holy Cross Germantown Hospital
  Icon-LinkedIn.png 

© 2015  Holy Cross Health | 1500 Forest Glen Road, Silver Spring, MD 20910 | 301-754-7000
trinity-health.org